PROPYLTHIOURACIL TABLETS
Identification of Propylthiouracil Tablets
| No description |
Google image searchProduct monograph
Active ingredient
propylthiouracil, 50 MG
DIN: 02523019
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: PHEBRA CANADA INC
Date: 21-JUL-2022
ATC:
- H03 — THYROID THERAPY (ATC, ATC/DDD, )
- H03B — ANTITHYROID PREPARATIONS (ATC, ATC/DDD)
- H03BA — Thiouracils (ATC, ATC/DDD)
- H03BA02 — PROPYLTHIOURACIL (ATC/DDD)
Reference brand drug: Halycil
Pharmaceutical standard: USP
